Clinical Trials Using Buparlisib
Clinical trials are research studies that involve people. The clinical trials on this list are studying Buparlisib. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Buparlisib or Alpelisib and Olaparib in Treating Patients with Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer
This phase I trial studies the side effects and best dose of buparlisib or alpelisib when given together with olaparib in treating patients with triple negative breast cancer or high grade serous ovarian cancer that has come back (recurrent). Buparlisib, alpelisib, and olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Location: See Clinical Trials.gov